Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 394 M366 M309 M333 M 1.4 B Research & development ———— — Operating income 216 M254 M263 M237 M 970 M Non-Operating Income, Total 92 M46 M38 M-98 M 78 M Interest expense, net of interest capitalized 54 M53 M54 M55 M 216 M Non-Operating Income, excl. Interest Expenses 38 M-7 M-16 M-153 M -138 M Unusual income/expense ———— — Pretax income 67 M131 M171 M-51 M 318 M Equity in earnings ———— — Taxes 49 M91 M61 M89 M 290 M Non-controlling/minority interest 2 M4 M3 M1 M 10 M After tax other income/expense 3 M5 M0-10 M -2 M Net income before discontinued operations 16 M36 M107 M-141 M 18 M Discontinued operations ———— — Net income 16 M36 M107 M-141 M 18 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 16 M36 M107 M-141 M 18 M Basic earnings per share (Basic EPS) 0.090.20.62-0.81 0.1 Diluted earnings per share (Diluted EPS) 0.090.20.61-0.8 0.1 Average basic shares outstanding 181.1 M177.43 M173.13 M175.02 M — Diluted shares outstanding 184.96 M179.15 M175.75 M178.65 M — EBITDA 376 M433 M459 M232 M 1.5 B EBIT 67 M131 M171 M-51 M 318 M Cost of revenue 2.39 B2.38 B2.44 B2.41 B 9.61 B Other cost of goods sold 2.39 B2.38 B2.44 B2.41 B 9.61 B Depreciation & amortization (cash flow) 309 M302 M288 M283 M 1.18 B